JP Morgan Maintains Neutral on Insulet, Raises Price Target to $170

Benzinga · 10h ago
JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $152 to $170.